Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dezocine versus sufentanil for postoperative depression and anxiety after laparoscopic colorectal cancer surgery
ChiCTR1800016246Phase 4Recruiting
- Sponsor
- Army Medical University
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dezocine and sufentanil in anxiety disorder and postoperative depression (2 arms), sponsored by Army Medical University. Primary endpoints: Beck depression scale and Beck anxiety scale. Started May 2018; status: recruiting.
02
Drugs
dezocinesufentanil
03
Conditions
anxiety disorderpostoperative depression
Beyond the preview
Go deeper on ChiCTR1800016246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016246.